The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.
A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...
The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.
The drug, Journavx, from Vertex Pharmaceuticals, reduced pain after surgery in clinical trials. Experts hope it can lead to fewer opioid prescriptions.
The novel formulation of rizatriptan and meloxicam (Symbravo, Axome Therapeutics) is for the acute treatment of migraine with ...
The FDA has approved a new type of painkiller that doesn't come with the risks of addiction and overdose associated with opioids.
The U.S. Food and Drug Administration (FDA) approved Thursday a new type of prescription pain medication for moderate to severe acute pain for adults.
This milestone marks a breakthrough after unsuccessful attempts to develop painkillers without the addictive potential of opioids.